Global Healthcare Gamification Market Expected to Grow at 11.0% CAGR and Gather $9,040.90 Million in the 2022-2031 Timeframe [250-Pages] | Affirmed by Research Dive
September 26, 2022 09:01 ET
|
Research Dive
New York, USA, Sept. 26, 2022 (GLOBE NEWSWIRE) -- According to Research Dive’s latest report, the global healthcare gamification market is anticipated to rise at a stunning CAGR of 11.0%, thereby...
Regenerative Medicine Market to Reach US$12.9Bn by 2028: TMR Study
September 14, 2022 10:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The last few years have witnessed a rise in awareness of regenerative medicines to help...
Asparaginase Market Size to Hit $1.57Bn, Globally, by 2028 Growing at 16.1% CAGR | Exclusive Report by The Insight Partners
August 24, 2022 06:11 ET
|
The Insight Partners
New York, Aug. 24, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Asparaginase Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type (Escherichia...
Global Rehabilitation Robots Market to Grow at a CAGR of ~26% During 2022-2031; Market to Grow owing to Rising Geriatric Population, High Prevalence of Neurological Diseases, and Increasing Technological Advancements
July 25, 2022 10:27 ET
|
Research Nester
New York, July 25, 2022 (GLOBE NEWSWIRE) -- As per the World Health Organization, every year, between 250000 to 500000 people suffer with a spinal cord injury in the world (SCI) although there is no...
Global Healthcare Gamification Market Anticipated to Generate a Revenue of $47,281.5 Million and Rise at a Healthy CAGR of 11.9% during the Forecast Period from 2019 to 2026 [120-Pages] | Research Dive
June 29, 2022 09:05 ET
|
Research Dive
New York, USA, June 29, 2022 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global healthcare gamification market is envisioned to generate a revenue of $47,281.5 million...
Exavir Therapeutics announces publication of preclinical data for ultra-long-acting dolutegravir prodrug XVIR-120
June 09, 2022 07:00 ET
|
Exavir Therapeutics
Ultra-long-acting plasma pharmacokinetics and biodistribution to tissues of interest demonstrated in three species Injections were well tolerated with no adverse findings in preliminary toxicology...
Next-Generation Antibody Market to hit $12.05 Bn, Globally, by 2028 at 11.9% CAGR, says The Insight Partners
June 08, 2022 09:30 ET
|
The Insight Partners
New York, June 08, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Next-Generation Antibody Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by...
Global Apheresis Market to Hit $5.3 Billion by 2031: Allied Market Research
June 08, 2022 07:45 ET
|
Allied Market Research
Portland, OR, June 08, 2022 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the global Apheresis Market generated $2.4 billion in 2021, and is expected to reach $5.3...
Exavir Therapeutics Completes $4M Seed Financing from Key Investors
May 23, 2022 07:00 ET
|
Exavir Therapeutics
NEW YORK and OMAHA, Neb., May 23, 2022 (GLOBE NEWSWIRE) -- Exavir Therapeutics, a company dedicated to transforming the lives of people living with or at risk of acquiring HIV, today announced that...
QSAM Biosciences Reports First Quarter 2022 Financial Results and Provides Corporate Update
May 17, 2022 08:00 ET
|
QSAM Biosciences Inc.
Dosed First Patient in Phase 1 Clinical Program Evaluating CycloSam® Radiopharmaceutical Drug Candidate for Treatment of Metastatic Bone Cancer Austin, TX, May 17, 2022 (GLOBE NEWSWIRE) -- QSAM...